merck keytruda - Search News

Order byBest matchMost fresh

News

Merck, Verona

· 1d · on MSN

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

Continue reading

· 2d · on MSN

Merck to Buy Verona for $10 Billion as Patent Cliff Looms

· 1d · on MSN

Merck to Buy Verona Pharma in $10 Billion Deal

3h

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

2d

Merck Faces Multiple Challenges: Will It Steer Through Successfully?

MRK banks on new launches as Keytruda faces a looming patent cliff and Gardasil weakens amid China's demand slump.

Pharmalittle: We’re reading about Trump’s latest tariff threat, a Merck deal, and lots more

President Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the U.S., but not immediately ...

3d

Merck & Co.: A Pharma Titan At A Discount

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

1d

Merck will have 'a lot more work to do' after Verona deal

Merck (MRK) is spending about $10 billion to acquire Verona Pharma (VRNA) as the company looks to fill future revenue gaps.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results